Historically, the ProMed team has partnered on 10-20 early-stage feasibility projects annually. In many instances our partners have identified the API of interest to address a clinical need and are in the process of drafting a target product profile (TPP). Leveraging past experience with a range of compounds and delivery methods, ProMed can advise on formulation, develop R&D analytical methods and rapidly demonstrate proof of concept in as little as 4-8 weeks.
